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It is generally accepted that admission into hospital is an experience best avoided avoided unless 
absolutely essential. As dermatologists, we pride ourselves on aspiring to and delivering the best 
evidence-based care for our patients with skin disease. What is the evidence to justify in-patient 
care for patients with skin disease? The background for this debate in the UK, and in most advanced 
heath care systems, is that admission into hospital for the management of severe skin diseases has 
been squeezed year-on-year by reductions in dermatology beds. Additionally, the need for in-patient 
care in dermatology has reduced dramatically with the introduction of newer, more effective 
treatments 1. The current reality for in-patient care for patients with skin disease in the NHS is far 
from ideal: usually remote from the dermatology team, patients can end up on any ward, 
surrounded by sick and elderly patients, and cared for by non-dermatology nurses.  
  
Oǀeƌ 70 Ǉeaƌs ago, RiĐhaƌd Asheƌ poiŶted out the ͞daŶgeƌs of goiŶg to ďed͟, aƌguiŶg that ǁe should 
do all we can to avoid or shorten hospital admission2. More recently, the Kings Fund report on 
Avoiding hospital admissions; what does the research evidence say? analysed issues around 
emergency admissions with a focus on evidence for prevention3. As dermatologists reading this 
report, we found it helpful; it describes the bigger picture of in-patient care in the NHS. But what 
does this report say about avoiding in-patient care for patients with skin disease? There is nothing 
specific, but plenty for dermatologists to think about. For example, the report asks which admissions 
aƌe aǀoidaďle, aŶd theŶ highlights ͞aŵďulatoƌǇ oƌ primary-care-seŶsitiǀe ĐoŶditioŶs͟. Most 
dermatology admissions in the past were patients who would have fitted this criterion. The report 
goes on to describe patient-self-management as a key element of avoiding hospital admission; 
although focused on asthma and COPD, it is just as relevant to patients with psoriasis and eczema. 
The report takes it as a given that in-patient care concerns patients for whom other options have run 
out and admission is essential. We found no research papers from the UK on avoiding hospital 
admission for patients with skin disease.  
 
In this era of evidence-based medicine, what evidence relates to in-patient care for patients with 
skin disease in the UK? We searched the literature and found very little. There are no systematic 
reviews or clinical guidelines on this topic; these require evidence, and research papers in this 
subject area are sparse. A study from the UK in 1995 confirmed that inpatient care greatly improved 
patieŶt’s ƋualitǇ of life, ďut laĐked data to eǆplaiŶ why in-patient care was needed for 230 patients 
over a six month period4. In 1999, Munro reported that only 18% of 300 dermatology patients 
admitted to hospital in Scotland would have required admission to a medical or surgical ward 5. A 
more recent UK study on in-patient care for psoriasis revealed an average length of stay of 19.7 
days, aiming to act as a benchmark for other units6, but made no attempt to justify or defend in-
patient care for psoriasis or to consider alternatives. More recently, analysis of children with 
dermatological conditions admitted to paediatric intensive care beds revealed skin infections, 
including cellulitis and necrotizing fasciitis, as the most frequent cause for admission; in 28% of 
cases, the dermatological diagnosis was considered the primary reason for admission 6. In the USA a 
total of 1.8% of hospital admissions for the years 2005 through 2011 were for adult patients with a 
skin infection as the primary diagnosis 7. Conspicuous by its absence is any health economic or 
qualitative research on dermatology admissions. Inpatient care ŵaǇ iŵpƌoǀe patieŶt’s ƋualitǇ of 
life9, but is extremely expensive. Furthermore, most people with skin disease prefer to avoid 
admission if possible.  
  
What are the alternatives to hospital admission in the NHS for those with bad skin disease?  
The ĐhaŶgiŶg eŶǀiƌoŶŵeŶt of hospitals iŶ the UK’s NH“ has foƌĐed ŵost deƌŵatologists to ǁoƌk 
differently; admitting patients for in-patient care is usually no longer possible nor desirable. 
Alternatives include day-care, phototherapies, systemic and biological therapies, hostel or hotel 
accommodation when attending a regional or national unit for two days or more, and care at home.  
As for phototherapy, day care must be locally accessible and convenient to be acceptable to 
patients. The usage of conventional systemic and biological therapies has risen dramatically at the 
same time as the dermatology beds have disappeared 1. Research has demonstrated that for 
psoriasis, patient flow towards systemic therapies and biologics is high in heath care systems where 
day care and phototherapy are poorly resourced or inaccessible 10. Care at home has been little 
studied in dermatology, with the exception of home phototherapy for psoriasis where equal efficacy 
and safety to hospital-based phototherapy has been demonstrated; home phototherapy was 
preferred by the patients in this study 11. The management of lower limb cellulitis has seen a UK-
wide change in clinical practice with patient care shifted from hospital to home 12. Finally, a recent 
report of successful care at home for severe exfoliative pityriasis rubra pilaris (PRP) suggests that 
alternative models of care can further reduce the need for in-patient care even for disorders such as 
PRP 13. Both of these last two examples of care shifting from hospital to the home required a high 
degree of integration between primary and secondary care services 12, 13. 
 
Which patients with skin disease still require in-patient care? The short answer is those who are non-
ambulatory; patients with such severe skin disease, with or without systemic problems, that 
intensive round the clock nursing and medical care is essential. Examples include: toxic epidermal 
necrolysis; severe erythema multiforme/Stevens Johnson syndrome; extensive pemphigus vulgaris 
or bullous pemphigoid; skin failure due to end-stage T-cell lymphoma; patients with severe genetic 
skin disease such as epidermolysis bullosa; younger patients with multi-system disease. These 
examples are easy to agree upon due to their severity and their impact on the patient who can no 
longer care for themselves. Other examples where in-patient care may also be needed include: 
elderly patients with multi-system disease that also includes skin disease; patients with severe 
vascular disease of the lower limbs with leg ulcers that fail to heal; patients with severe psoriasis or 
severe eczema who have failed on biological therapies and cannot care for themselves at home; 
patients with severe skin or subcutaneous infection.  In view of this continuing need for inpatient 
care, appropriate provision for this must be included when commissioning dermatology care. 
 
Thus, there are a number of categories where in-patient care for skin disease is still important. 14, 15 
What is the best model of care for these patients (Fig 1)? Elderly and infirm patients with multiple 
problems are best cared for on a specialist ward for care of the elderly, with a visiting dermatology 
team including regular care from visiting dermatology specialist nurses. Similarly, some younger 
adults with multiple co-morbidities may be most effectively managed on a general medical ward, 
with a visiting dermatology team. Cultural influences and factors other than disease severity alone 
may play a role in admission 16.  There may also be geographic reasons leading to admission: the use 
of hostel or ͞hotel͟ ďeds ŵaǇ oǀeƌĐoŵe soŵe of these practical constraints.  There is an argument 
that patients with some very rare conditions should be cared for in specialised units, such as plastic 
surgery burns units for toxic epidermal necrolysis (TEN), the TEN service in Creteuil, France 17, or the 
epidermolysis bullosa UK in-patient facilities in Birmingham and London 18. Patients with skin failure 
due to end-stage T-cell lymphoma of the skin are best cared for at home or hospice, with skilled end-
of-life palliative care nurses as part of the care team 19.  Patients with severe vascular disease of the 
legs and recalcitrant leg ulcers are best cared for by vascular surgical teams, with advice on skin care 
from a visiting dermatology team 20. Children and adults with severe skin infection are best managed 
on intensive care units or an acute medical ward, with input from a visiting dermatology team 6,7, 12.   
 
In conclusion, we need evidence-based decisions concerning the pattern of future dermatology in-
patient care, informed by patient needs and preferences.  UK  Dermatologists must now take the 
lead by negotiating for high quality, accessible outpatient and day-treatment facilities to replace the 
lost dermatology wards. For this to succeed, high levels of integration between secondary and 
primary care services are needed 3, with a greater emphasis on placing our patients at the centre of 
their own health care and facilitating their self-management 21.  There is now an urgent need for 
qualitative and health economic research to ensure that future provision and organisation of 
inpatient services are optimised for our patients. 
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Figure 1. 
 
Skin conditions where patients may require in-patient care, and the teams that care for them in 
today’s NHS   
 
Condition Clinical teams 
Toxic epidermal necrolysis Specialised burns team and dermatology team 
Severe erythema multiforme/SJS Specialised burns team and dermatology team 
Severe pemphigus vulgaris or 
severe bullous pemphigoid 
Medical team on a high dependency unit; rarely anaesthetics 
team on intensive care unit and dermatology team 
Skin failure in end-stage T-cell 
lymphoma of skin 
Palliative care services/ Care at home and dermatology team 
Severe, congenital skin diseases 
such as epidermolysis bullosa 
Local dermatology team in collaboration with national 
specialist centres 
Patients with multi-system auto-
immune disorders 
Rheumatology team in specialised regional unit or local 
physicians on a local medical ward and dermatology team 
Elderly frail patients with 
multiple co-morbidities, including 
skin disease 
Care of the elderly team and dermatology team 
Patients with severe lower-limb 
vascular disease and leg ulcers 
Vascular surgeons and dermatology team 
Severe skin infection Intensive care/general medical team and dermatology team 
 
